At Cellistic, iPSC scale-up isn’t a flavor-of-the-day. It’s a first language. It’s a promise waiting to be kept. It’s how the next generation of allogeneic cell therapy innovators will improve patients’ lives everywhere. And it’s all driven here by a team with deep, diverse expertise in the business and science of cell therapy.  

Stefan Braam, PhD

CEO

Elena Matsa, PhD

Vice President of
Cell Technology

Andy Holt

Chief Commercial Officer

Benjamin Demoulin, PhD

Director of 
Cell Therapy Innovation 

Eva D’amico, PhD

Senior Scientist

Teaming up with Cellistic

Your best science deserves our best thinking, capabilities and technology. Let’s start exploring how our combined expertise can help you achieve your cell therapy ambitions.